BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 6, 2013
View Archived Issues
BioFire commences studies to support U.S. and E.U. approval of FilmArray GI Panel
Read More
Takeda reviews highlights of first quarter of fiscal 2013
Read More
ReNeuron awarded grant for phase II stroke trial
Read More
Siga Technologies selects candidate for dengue fever program
Read More
Actelion agrees to acquire Ceptaris Therapeutics pending Valchlor approval
Read More
PharmAthene and Theraclone Sciences sign definitive merger agreement
Read More
Kinex Pharmaceuticals obtains research support
Read More
Clinical studies reveal promise for OptiNose Breath Powered sumatriptan for migraine
Read More
P2X1 receptor revealed as a target in transfusion-related acute lung injury
Read More
Amblyomin-X has anticoagulant and oncolytic activity
Read More
Dainippon Sumitomo Pharma offers overview of first quarter of fiscal 2013
Read More
U.S. group presents novel oligonucleotides for familial dysautonomia
Read More
GW Pharmaceuticals reports data from Sativex study in MS spasticity
Read More
Isis Pharmaceuticals reports data from phase II ISIS-CRPRx study
Read More
Sanofi Pasteur launches phase III program for C. difficile vaccine
Read More
Compugen and Bayer sign agreement for antibody-based anticancer immunotherapies
Read More
PDUFA date for diabetes candidate albiglutide extended 3 months
Read More
Synergy Pharmaceuticals reaches agreement with FDA for plecanatide phase III program
Read More
Analyses detail nausea, efficacy and assembly of the sumatriptan iontophoretic transdermal system
Read More
Aradigm receives NIH grant for Pulmaquin and Lipoquin
Read More
EMA extends review of Clinuvel's SCENESSE to January 2014
Read More
Ono Pharmaceutical stops study of remimazolam in Japan; phase II study approved in Germany
Read More
The Medicines Company completes acquisition of ProFibrix following phase III results for Fibrocaps
Read More